Adimab's Series E Round

Adimab raised a round of funding on November 30, 2010.

Adimab is engaged in the discovery, maturation and production of therapeutic human antibodies. Per the company, Adimab integrates all aspects of antibody discovery and sophisticated screening methods,…

Articles about Adimab's Series E Round: